浙江医药：关于向2025年限制性股票激励计划激励对象授予限制性股票的公告

Core Viewpoint - Zhejiang Medicine announced the approval of a restricted stock incentive plan for 2025, granting 10.284 million shares to 875 recipients at a price of 7.30 yuan per share [1] Group 1 - The company held its 10th ninth board meeting on November 26, 2025, to review the incentive plan [1] - The conditions for granting restricted stock to the incentive plan participants have been met as of the grant date [1] - The stock grant is part of the company's strategy to motivate and retain key personnel [1]